Cargando…

Gene therapy for cancer: regulatory considerations for approval

The rapidly changing field of gene therapy promises a number of innovative treatments for cancer patients. Advances in genetic modification of cancer and immune cells and the use of oncolytic viruses and bacteria have led to numerous clinical trials for cancer therapy, with several progressing to la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husain, S R, Han, J, Au, P, Shannon, K, Puri, R K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722245/ https://www.ncbi.nlm.nih.gov/pubmed/26584531 http://dx.doi.org/10.1038/cgt.2015.58

Ejemplares similares

Scientific and Regulatory Considerations for the Approval of the First Generic Glucagon
por: Pang, Eric, et al.
Publicado: (2021)

Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies
por: Moffit, Jeffrey S., et al.
Publicado: (2022)

USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS
por: Lu, Kevin, et al.
Publicado: (2022)

On the Regulatory Approval Pathway of Biosimilar Products
por: Wang, Jun, et al.
Publicado: (2012)

Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval
por: Strauss, David G., et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
por: Fernández-Garza, Luis E., et al.
Publicado: (2023)

Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations
por: Junnuthula, Vijayabhaskarreddy, et al.
Publicado: (2022)

Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
por: Ro, Sunhee K., et al.
Publicado: (2023)

An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins
por: Heinemann, Lutz, et al.
Publicado: (2015)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers
por: Zou, Limin, et al.
Publicado: (2023)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
por: Tong, Juliana T. W., et al.
Publicado: (2021)

The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics
por: Goodsaid, Federico M.
Publicado: (2019)

A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies
por: White, Michael, et al.
Publicado: (2017)

Current State of Human Gene Therapy: Approved Products and Vectors
por: Shchaslyvyi, Aladdin Y., et al.
Publicado: (2023)

 Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan 
por: Halioua-Haubold, Celine-Lea, et al.
Publicado: (2017)

Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy
por: Pinkerton, JoAnn V., et al.
Publicado: (2016)

Adverse events of targeted therapies approved for women's cancers
por: Saint-Ghislain, Mathilde, et al.
Publicado: (2021)

Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
por: Gomes-da-Silva, Lígia C., et al.
Publicado: (2020)

China approves first gene therapy
por: Pearson, Sue, et al.
Publicado: (2004)

Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders
por: Cotovio, Gonçalo, et al.
Publicado: (2023)

Solution Oligonucleotide APIs: Regulatory Considerations
por: Wetter, Christian, et al.
Publicado: (2022)

Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
por: Watanabe, Natsumi, et al.
Publicado: (2015)

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021
por: Lau, Catherine, et al.
Publicado: (2022)

From fiction to science: clinical potentials and regulatory considerations of gene editing
por: Schacker, Maria, et al.
Publicado: (2019)

Recent Least Burdensome Approach for the Approval of Innovative Medical Devices in Japan -Regulatory Approval Review of an Everolimus-eluting Bioresorbable Scaffold-
por: Konishi, Akihide, et al.
Publicado: (2020)

Regulatory approval pathway for COVID-19 vaccine in USA, Europe and India
por: Narasimhan, Jaipratap, et al.
Publicado: (2023)

Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries
por: Franco, Pedro, et al.
Publicado: (2022)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations
por: Dobbin, Kevin K., et al.
Publicado: (2016)

Side Effects of Cytokines Approved for Therapy
por: Baldo, Brian A.
Publicado: (2014)

The global landscape of approved antibody therapies
por: Lyu, Xiaochen, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

Regulatory approval of new medical devices: cross sectional study
por: Marcus, Hani J, et al.
Publicado: (2016)

Requirements and Study Designs for U.S. Regulatory Approval of Influenza Home Tests
por: Yang, Tony, et al.
Publicado: (2022)

Trial designs using real‐world data: The changing landscape of the regulatory approval process
por: Baumfeld Andre, Elodie, et al.
Publicado: (2019)

Monoclonal Antibodies Approved for Cancer Therapy
por: Baldo, Brian A.
Publicado: (2016)

Review of successful pathways for regulatory approvals in open-field fluorescence-guided surgery
por: Pogue, Brian W., et al.
Publicado: (2021)

Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015)

Regulatory considerations for paediatric drug evaluation in China
por: Geng, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k1esql9kg59m378mhccl52r2k9